Vaginal discharge unassociated with sexually transmitted infections in reproductive-aged women

1. Venugopal S., Gopalan K., Devi A., Kavitha A. Epidemiology and clinico-investigative study of organisms causing vaginal discharge. Indian J. Sex. Transm. Dis. AIDS. 2017; 38(1): 69-75.

2. Zemouri C., Wi T.E., Kiarie J., Seuc A., Mogasale V., Latif A., Broutet N. The performance of the vaginal discharge syndromic management in treating vaginal and cervical infection: a systematic review and meta-analysis. PLoS One. 2016; 11(10): e0163365. doi: 10.1371/journal.pone.0163365. eCollection 2016.

3. Sivaranjini R., Jaisankar T., Thappa D.M., Kumari R., Chandrasekhar L.,Malathi M. et al. Spectrum of vaginal discharge in a tertiary care setting. Trop. Parasitol. 2013; 3(2): 135-9. doi: 10.4103/2229-5070.122140.

4. Green K.A., Zarek S.M., Catherino W.H. Gynecologic health and disease in relation to the microbiome of the female reproductive tract. Fertil. Steril. 2015; 104(6): 1351-7.

5. Lewis W.G., Robinson L.S., Gilbert N.M., Perry J.C., Lewis A.L. Degradation, foraging, and depletion of mucus sialoglycans by the vagina-adapted Actinobacterium Gardnerella vaginalis. J. Biol. Chem. 2013; 288(17): 12067-79.

6. Amabebe Е., Anumba D.O.C. The vaginal microenvironment: the physiologic role of Lactobacilli. Front. Med. (Lausanne). 2018; 5: 181.

7. Petrova M.I., Lievens E., Malik S., Imholz N., Lebeer S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front. Physiol. 2015; 6: 81.

8. Мелкумян А.Р., Припутневич Т.В. Влагалищные лактобактерии – современные подходы к видовой идентификации и изучению их роли в микробном сообществе. Акушерство и гинекология. 2013; 7: 18-23. [Melkumyan A.R., Priputnevich T.V. Vaginal lactobacilli - modern approaches to species identification and the study of their role in the microbial community. Obstetrics and gynecology. 2013; 7: 18-23. (in Russian)]

9. Smith S.B., Ravel J. The vaginal microbiota, host defence and reproductive physiology. J. Physiol. 2017; 595(2): 451-63.

10. Ravel J., Gajer P., Abdo Z., Schneider G.M., Koenig S.S., McCulle S.L. et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA. 2011; 108(Suppl. 1): 4680-7.

11. MacIntyre D.A., Chandiramani M., Lee Y.S., Kindinger L., Smith A., Angelopoulos N. et al. The vaginal microbiome during pregnancy and the postpartum period in a European population. Sci. Rep. 2015; 5: 8988.

12. Petrova M.I., Reid G., Vaneechoutte M., Lebeer S. Lactobacillus iners: friend or foe? Trends Microbiol. 2017; 25(3): 182-91.

13. Keelan J.A. Pharmacological inhibition of inflammatory pathways for the prevention of preterm birth. J. Reprod. Immunol. 2011; 88(2): 176-84.

14. Witkin S.S., Linhares I.M. Why do lactobacilli dominate the human vaginal microbiota? BJOG. 2016; 124(4): 606-11.

15. Любасовская Л.А., Мелкумян А.Р., Дубоделов Д.В., Родченко Ю.В., Муравьева В.В., Кондрахин А.П., Майкова Г.Б., Амирханян А.С., Николаева Н.В., Байрамова Г.Р., Припутневич Т.В. Опыт применения женских гигиенических средств, содержащих пробиотический штамм Lactobacillus acidophilus у женщин репродуктивного возраста и в постменопаузе для профилактики оппортунистических инфекций влагалища. Акушерство и гинекология. 2018; 9: 126-31.[Lyubasovskaya L.A, Melkumyan A.R., Dubodelov D.V., Rodchenko Yu.V., Muravyova V.V., Kondrakhin A.P, Maykova G.B., Amirkhanyan A.S., Nikolayeva N.V., Bayramova G.R., Priputnevich T.V. Experience in the use of feminine hygiene products containing the probiotic strain Lactobacillus acidophilus in women of reproductive age and in postmenopausal women for the prevention of opportunistic infections of the vagina. Obstetrics and gynecology. 2018; 9: 126-31. (in Russian)]

16. Srinivasan S., Morgan M.T., Fiedler T.L., Djukovic D., Hoffman N.G., Raftery D. et al. Metabolic signatures of bacterial vaginosis. MBio. 2015; 6(2). pii: e00204-15. doi: 10.1128/mBio.00204-15.

17. Joziani B., Paulo C.G., Iara M.L., William J.L., Steven S.W. Neutrophil gelatinase-associated lipocalin concentration in vaginal fluid: relation to bacterial vaginosis and vulvovaginal candidiasis. Reprod. Sci. 2015; 22(8): 964-8.

18. Onderdonk A.B., Delaney M.L., Fichorova R.N. The human microbiome during bacterial vaginosis. Clin. Microbiol. Rev. 2016; 29(2): 223-38.

19. Muhleisen A.L., Herbst-Kralovetz M.M. Menopause and the vaginal microbiome. Maturitas. 2016; 91: 42-50.

20. Jung H.S., Ehlers M.M., Lombaard H. Etiology of bacterial vaginosis and polymicrobial biofilm formation. Crit. Rev. Microbiol. 2017; 43(6): 651-67. doi: 10.1080/1040841X.2017.1291579.

21. Vieira-Baptista P., Lima-Silva J., Pinto C., Saldanha C., Beires J., Martinez-de-Oliveira J. et al. Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities. Eur. J. Clin. Microbiol. Infect. Dis. 2016; 35(4): 657-64.

22. Mason M.J., Winter A.J. How to diagnose and treat aerobic and desquamative inflammatory vaginitis. Sex. Transm. Infect. 2017; 93(1): 8-10.

23. Sherrard J., Wilson J., Donders G., Mendling W., Jensen J.S. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int. J. STD AIDS. 2018; 29(13): 956462418785451.

24. Байрамова Г.Р., Баранов И.И., Припутневич Т.В., Чернова В.Ф. Вульвовагинальный кандидоз: клинические и терапевтические аспекты в практике акушера-гинеколога. Акушерство и гинекология. 2017; 4: 63-9. [Bayramova G.R., Baranov I.I., Priputnevich T.V., Chernova V.F. Vulvovaginal candidiasis: clinical and therapeutic aspects in the practice of an obstetrician-gynecologist. Obstetrics and gynecology. 2017; 4: 63-9. (in Russian)]

25. Sobel J.D. Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis. Patient Prefer Adherence. 2014; 8: 31-4.

26. Ковалык В.П. Хламидийная инфекция в гинекологии: современные тренды патогенеза диагностики и лечения. Гинекология. 2013; 15(2): 42-7. [Kovalyk V.P. Chlamydial infection in gynecology: current trends in the pathogenesis of diagnosis and treatment. Gynecology. 2013; 15 (2): 42-7. (in Russian)]

27. Plummer E.L., Vodstrcil L.A., Danielewski J.A., Murray G.L., Fairley C.K., Garland S.M. et al. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples. PLoS One. 2018; 13(1): e0190199.

28. Карапетян Т.Э., Муравьева В.В., Анкирская А.С., Любасовская Л.А., Припутневич Т.В. Возможности лечения оппортунистических инфекций влагалища во время беременности. Гинекология. 2017; 19(6): 11-5. [Karapetyan T.E., Muravyova V.V., Ankirskaya A.S., Lyubasovskaya L.A., Priputnevich T.V. Treatment options for opportunistic vaginal infections during pregnancy. Gynecology. 2017; 19 (6): 11-5. (in Russian)]

29. Manhart L.E., Khosropour C.M., Liu C., Gillespie C.W., Depner K., Fiedler T. et al. Bacterial vaginosis-associated bacteria in men: association of Leptotrichia/Sneathia spp. with nongonococcal urethritis. Sex. Transm. Dis. 2013; 40(12): 944-9.

Received 10.10.2018

Accepted 07.12.2018